Bolesław Rutkowski

Author PubWeight™ 51.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease. Pol Arch Med Wewn 2013 2.00
2 Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens 2007 1.74
3 Current diagnostic evaluation of autosomal dominant polycystic kidney disease. Pol Arch Med Wewn 2008 1.10
4 Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Am J Kidney Dis 2008 1.09
5 Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs 2010 1.07
6 [Modern treatment of autosomal dominant polycystic kidney disease]. Pol Merkur Lekarski 2008 1.06
7 Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol 2008 0.92
8 Continuous cognitive improvement 1 year following successful kidney transplant. Kidney Int 2011 0.92
9 Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol 2010 0.90
10 [Hypertensive nephropathy: pathogenesis, diagnosis and treatment]. Pol Merkur Lekarski 2003 0.89
11 Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells. Mech Ageing Dev 2010 0.88
12 Serum concentration of amino acids versus nutritional status in hemodialysis patients. J Ren Nutr 2008 0.86
13 Cognitive performance before and after kidney transplantation: a prospective controlled study of adequately dialyzed patients with end-stage renal disease. J Int Neuropsychol Soc 2009 0.85
14 Remarks on surgical strategy in creating vascular access for hemodialysis: 18 years of one center's experience. Ann Vasc Surg 2005 0.84
15 Direct renin inhibition--a promising strategy for renal protection? Med Sci Monit 2013 0.84
16 Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives. Kidney Blood Press Res 2005 0.83
17 Increased pheromone cCF10 expression in Enterococcus faecalis biofilm formed by isolates from renal transplant patients. Curr Microbiol 2012 0.82
18 Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients. Nephrol Dial Transplant 2002 0.82
19 Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis? Med Sci Monit 2003 0.81
20 Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study. Arch Med Res 2007 0.81
21 Flow cytometric analysis of STAT5 phosphorylation and CD95 expression in CD4+ T lymphocytes treated with recombinant human erythropoietin. J Recept Signal Transduct Res 2011 0.81
22 Posttransplant encapsulating peritoneal sclerosis: presentation of cases and review of the literature. J Nephrol 2012 0.81
23 Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol 2010 0.80
24 Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease. Am J Hypertens 2012 0.80
25 Treatment with recombinant human erythropoietin is associated with rejuvenation of CD8+ T cell compartment in chronic renal failure patients. Nephrol Dial Transplant 2007 0.80
26 Carnitine content in different muscles of patients receiving maintenance hemodialysis. J Ren Nutr 2007 0.80
27 The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study. Kidney Blood Press Res 2008 0.80
28 Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy. Am J Nephrol 2004 0.79
29 Does CMV infection impact the virulence of Enterococcus faecalis? Virulence 2013 0.79
30 [Sensitivity for antibiotics among the E. coli strains isolated from patients with different clinical stage of infection]. Przegl Lek 2012 0.79
31 Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients. Nephrol Dial Transplant 2004 0.79
32 Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis. Am J Nephrol 2007 0.79
33 Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Ann Acad Med Stetin 2008 0.79
34 Chronic food restriction differentially affects NPY mRNA level in neurons of the hypothalamus and in neurons that innervate liver. Neurosci Lett 2008 0.79
35 High level of negative emotions in hemodialysis patients suggests the need for therapy. Nephron 2002 0.79
36 The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. Med Sci Monit 2010 0.78
37 [Genetic predisposition to systemic complications of arterial hypertension in maintenance haemodialysis patients]. Pol Merkur Lekarski 2008 0.78
38 Nicotinamide metabolites accumulate in the tissues of uremic rats. J Ren Nutr 2008 0.78
39 Risk factors for selective cognitive decline in dialyzed patients with end-stage renal disease: evidence from verbal fluency analysis. J Int Neuropsychol Soc 2011 0.78
40 Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regul Pept 2011 0.77
41 [Influence of erythropoietin on immunological system of patients with chronic renal failure]. Pol Merkur Lekarski 2003 0.77
42 Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. Med Sci Monit 2005 0.77
43 [The effect of therapy with small doses of mega-3 polyunsaturated fatty acid on renal reserve and metabolic disturbances in patients with primary IGA glomerulopathy]. Pol Arch Med Wewn 2002 0.77
44 Treatment of hypertension in chronic kidney disease patients under specialized care: one-center cross-sectional analyses. Blood Press 2014 0.77
45 Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study. Scand J Urol Nephrol 2008 0.77
46 Vitamin B6 and the immunity in kidney transplant recipients. J Ren Nutr 2012 0.77
47 [Early diagnosis of renal diseases--preliminary results from the pilot study PolNef]. Przegl Lek 2005 0.77
48 Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial. Int Urol Nephrol 2012 0.77
49 Determinants of anxiety in patients with advanced somatic disease: differences and similarities between patients undergoing renal replacement therapies and patients suffering from cancer. Int Urol Nephrol 2012 0.77
50 Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results. Acta Biochim Pol 2009 0.77
51 Tubular injury: the first symptom of hypertensive kidney involvement? Med Sci Monit 2003 0.77
52 Benefits and menaces related to the use of statins in patients after renal transplantation. Ann Transplant 2002 0.76
53 [Vitamins and microelements in patients with chronic kidney disease]. Wiad Lek 2014 0.76
54 Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome. Rheumatol Int 2007 0.76
55 The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?. Kidney Blood Press Res 2012 0.76
56 Urinary tract infections during the first year after renal transplantation: one center's experience and a review of the literature. Clin Transplant 2014 0.76
57 [Program of early diagnosis of chronic renal disease in children--SopKard 15 nephrological project]. Pol Merkur Lekarski 2008 0.76
58 [Life threatening drug-induced hyperkaliemia--case report]. Pol Arch Med Wewn 2006 0.75
59 Initiation of dialysis--the right timing and the right tools. Nephrol Dial Transplant 2009 0.75
60 Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future? Authors' reply. Pol Arch Med Wewn 2014 0.75
61 Megestrol acetate use in hypoalbuminemic dialysis patients. J Ren Nutr 2011 0.75
62 Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients. Int Urol Nephrol 2011 0.75
63 Activities of lipogenic enzymes in subcutaneous adipose tissue are not increased in patients with chronic kidney failure. Pol Arch Med Wewn 2012 0.75
64 [Mycophenolate mofetil--20 years of experience in treatment of rheumatic diseases]. Postepy Hig Med Dosw (Online) 2015 0.75
65 [Lipid disturbances in the nephrotic syndrome]. Przegl Lek 2003 0.75
66 [Vitamin B-6 in chronic renal insufficiency]. Przegl Lek 2006 0.75
67 Enzymatic examination of potential interaction between statins or fibrates and consumed Tricholoma equestre. Przegl Lek 2005 0.75
68 [Genetic basis of dyslipidemia]. Przegl Lek 2009 0.75
69 [Mechanisms of statin nephroprotective actions]. Przegl Lek 2002 0.75
70 [Pentoxifylline old drug or new hope for nephrology?]. Przegl Lek 2008 0.75
71 [Quality of life and therapy in the elderly patients on chronic peritoneal dialysis]. Pol Merkur Lekarski 2003 0.75
72 [Isoprostanes - important marker of the oxidative stress estimation in patients with chronic kidney disease]. Pol Merkur Lekarski 2013 0.75
73 Effects of renal-specific oral supplementation in malnourished hemodialysis patients. J Ren Nutr 2010 0.75
74 [Molecular mechanism of fatty acids impact on plasma lipid profile (part II)]. Przegl Lek 2007 0.75
75 [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms]. Wiad Lek 2006 0.75
76 Adult pre-emptive kidney transplantation: a paired kidney analysis. Transpl Int 2011 0.75
77 [Problem of HIV-infected patients receiving dialysis]. Przegl Lek 2004 0.75
78 [Metabolic acidosis after kidney transplantation]. Przegl Lek 2005 0.75
79 Manual aspiration thrombectomy complemented with local thrombolysis for acute renal artery embolism. Pol Arch Med Wewn 2015 0.75
80 Bioelectrical impedance analysis before versus after a hemodialysis session in evaluation of nutritional status. J Ren Nutr 2006 0.75
81 [Risk factors for skin cancer development in patients after organ transplantation]. Postepy Hig Med Dosw (Online) 2012 0.75
82 [Diagnostic value of specific anty-HLA alloantibodies before and after renal transplantation. Programs for highly sensitized recipients]. Postepy Hig Med Dosw (Online) 2009 0.75
83 Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study. Transpl Int 2007 0.75
84 [Groin hernia in the patients receiving CAPD]. Wiad Lek 2005 0.75
85 [The evaluation of mineral crystallinity of mandibular bone tissue using electron paramagnetic resonance (EPR) in patients suffering from renal osteodystrophy]. Przegl Lek 2006 0.75
86 Regression of long standing anorexia nervosa following acute renal failure caused by gentamicin intoxication. Przegl Lek 2005 0.75
87 [The nephrological knowledge of patricipants of World Kidney Day 2012 in Gdańsk center]. Wiad Lek 2014 0.75
88 [Peritoneal dialysis as an alternative in the treatment of patient with heart failure refractory to conventional therapy]. Kardiol Pol 2013 0.75
89 Palliative care in nephrology. J Nephrol 2008 0.75
90 [Estimation of the frequency of occurrence of microorganisms isolated from blood cultures of hospitalized patients in the Hospital of Medical University in Gdańsk in 2000-2002]. Przegl Epidemiol 2007 0.75
91 [The conjugated linoleic acids in prevention and treatment of obesity]. Przegl Lek 2007 0.75
92 [What the nephrologist should know about antiphospholipid syndrome?]. Pol Merkur Lekarski 2009 0.75
93 [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline]. Przegl Lek 2008 0.75
94 Manual aspiration thrombectomy complemented with local thrombolysis for acute renal artery embolism. Pol Arch Med Wewn 2015 0.75
95 [Molecular mechanism of fatty acids impact on plasma lipid profile (part I)]. Przegl Lek 2007 0.75
96 The history of nephrology in Poland. J Nephrol 2006 0.75
97 [Endothelial dysfunction in peritoneal dialysis patients and its relationship to nutrition]. Pol Merkur Lekarski 2006 0.75
98 [Late drug-induced hyperkalemia in a patient with congestive heart failure]. Przegl Lek 2005 0.75
99 Cardiovascular risk in patients undergoing maintenance hemodialysis with Helixone® membrane: a multicenter randomized study. Pol Arch Med Wewn 2014 0.75
100 Thiamine Diphosphate Status and Dialysis-Related Losses in End-Stage Kidney Disease Patients Treated with Hemodialysis. Blood Purif 2017 0.75
101 Leon Marchlewski: one of the precursors of clinical chemistry. J Nephrol 2011 0.75
102 A single-center experience of renal transplantation in elderly patients: a paired-kidney analysis. Transplantation 2007 0.75
103 Effectiveness of antihypertensive treatment in patients with chronic kidney disease. J Ren Nutr 2008 0.75
104 [Can platelets be synthetized from nucleotides?]. Pol Arch Med Wewn 2004 0.75